Certain studies have concluded that it may be caused by STEAP3 activating the TfR-STAT3 pathway in GBM, and that knockdown of the transferrin receptor (TfR) significantly influences the impact of STEAP3 overexpression on malignant phenotypes in GSCs (42, 43). Here, STEAP3 is linked to glioblastoma.